---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-074258"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:09:17.033512+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology annual meeting results: all three director nominees elected, proposals approved

## Summary
- Corey Goodman, Jason Lettmann, Sophia Randolph elected as Class I directors for terms until 2027.
- Advisory vote on executive compensation approved: 40,935,354 for, 1,422,239 against, 34,391 abstain.
- Ratification of KPMG as independent auditor for FY 2024 approved: 47,698,670 for, 11,338 against, 2,733 abstain.
- Broker non-votes: 5,320,757 on director elections and advisory compensation vote.

## SEC filing metadata
- accession: 0000950170-24-074258
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000095017024074258/0000950170-24-074258-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000095017024074258/alxo-20240612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-074258
- JSON: https://secwatch.observer/filing/0000950170-24-074258.json
- Plain text: https://secwatch.observer/filing/0000950170-24-074258.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.